Thomas Patrick Kelly - 17 Jan 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.

Role
Chief Financial Officer
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Jan 2023
Net transactions value
-$51,043
Form type
4
Filing time
19 Jan 2023, 15:05:44 UTC
Previous filing
21 Jun 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale $51,043 -2,403 -5.2% $21.24 43,677 17 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock.